A recombinant fragment of Helicobacter pylori CagA affects proliferation of human cells

Journal of Physiology and Pharmacology

Volumn 49, Issue 1, 1998, Pages 111-119

  Rudnicka, W ^a   Covacci, A ^b   Wadstrom, T ^c   Chmiela, M ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b Istituto Ricerche Immunobiologiche   (Italy)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Cell proliferation; Helicobacter pylori; rCagA

Indexed keywords

BACTERIAL ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYBRID PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; HELA CELL; HUMAN; HUMAN CELL; MONOCYTE; STOMACH CARCINOMA; T LYMPHOCYTE;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CELL DIVISION; CELL LINE; HELA CELLS; HELICOBACTER PYLORI; HUMANS; MONOCYTES; PEPTIDE FRAGMENTS; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES;

EID: 0031961295     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Xiang ZY, Censini S, Bayeli PF et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995; 63: 94-98.
2. Covacci A, Censini S, Bugnoli M. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated cytotoxicity and duodenal ulcer. Proc Acad Sci USA 1993; 90: 5791-5795.
3. Karhukorpi J, Ikaheimo J, Silvennoimen, Kassimen S, Tiilikainen A, Karttunnen R. Homozygosity of alleles DQA10103, 0301 or 0501 predisposes to Helicobacter pylori infection. Ir J Med Sci 1997; 166: Suppl. 3, 9.
4. Marchetti M, Arico B, Burroni D, Figura N, Rappuoli R, Ghiara P. Development of mouse model of Helicobacter pylori infection that mimics human disease. Science 1995; 267: 1655-1658.
5. Lee A, Fox J, Hazell S. Pathogenicity of Helicobacter pylori: a perspective. Infect Immun 1993; 61: 1601-1610.
6. Crabtree JE, Wyatt JI, Sobala GM et al. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut 1993; 34: 1339-1343.
7. Knipp U, Birkholz S, Kaup W, Opferkuch W. Immunosuppressive effects of Helicobacter pylori on human peripheral blood mononuclear cells. Med Microbiol Immunol 1993; 182: 63-68.
8. Knipp U, Birkholz S, Kaup W, Operkuch W. Partial characterization of a cell proliferation-inhibiting protein produced by Helicobacter pylori. Infect Immun 1996; 64: 3491-3496.
9. 1-cell cycle arest of the cell line U937. Ir J Med Sci 1997; 166: 16.
10. Karttunen A, Andersson G, Poikonen K. Helicobacter pylori induces lymphocyte activation in peripheral blood cultures. Clin Exp Immunol 1990; 82: 485-490.
11. Karttunen R. Blood lymphocyte proliferation, cytokine secretion and appearence of T-cells with activation surface markers in cultures with Helicobacter pylori. Comparison of the response of subjects with and without antibodies to H. pylori. Clin Exp Immunol 1991; 83: 396-400.
12. Bamford KB. T-cell responses to Helicobacter pylori antigens. Ir J Med Sci 1997; 166: 3.
13. Fan XJ, Chua CN, Mc Devitt J, Keeling PW, Kelleher D. Gastric T lymphocyte responses to Helicobacter pylori in patients with H. pylori colonization. Gut 1994; 35: 1379-1384.
14. Chmiela M, Lelwala-Guruge JA, Wadstrom T, Rudnicka W. The stimulation and inhibition of T cell proliferation by Helicobacter pylori components. J Physiol Phyrmacol 1996; 47: 195-202.
15. Chmiela M, Paziak-Domańska B, Ljung A, Wadstrom T, Rudnicka W. The proliferation of human T lymphocytes stimulated by Helicobacter pylori antigens. Immunobiology 1996; 195: 199-208.
16. Xiang Z, Bugnoli M, Ponzetto A et al. Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kilodalton protein (CagA) of Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1993; 12: 739-745.
17. Knight SC, Farrant J, Bryant A. Non-adherent, low-density cells from human peripheral blood contain dendritic cells and monocytes, both with veiled morphology. Immunology 1986; 57: 595-600.
18. Rechciński T, Chmiela M, Malłecka-Panas E, Plłaneta-Malłecka I, Rudnicka W. Serological indicators of Helicobacter pylori infection in adult dyspeptic patients and healthy blood donors. Microbiol Immunol 1997; 41: 387-393.
19. Karczewska E, Bobrzynski A, Konturek SJ, Pierzchalski P, Kleanthous H. Serum CagA antibody in gastric diseases in Helicobacter pylori (Hp) infected patients. Ir J Med Sci 1997; 166: Suppl. 3: 19.
20. + Helicobacter pylori strains. J Clin Microbiol 1995; 33: 1496-1500.
21. Marshall DG, Coleman DC, O'Morain CA, Smyth CJ. Phenotypic and genotypic characterization of a Helicobacter pylori strain collection. Ir J Med Sci 1997; 166: Suppl. 3: 29.
22. Miehlke S, Bayerdorffer E, Lehn N, Schweiger K, Graham DY, Go MF. Cytotoxin activity and vacA subtypes in H. pylori associated with malt lymphoma or simple gastris. Ir J Med Sci 1997; 166: Suppl. 3: 28.
23. Ghiara P. Mucosal vaccines: perspectives of the development of antiulcer vaccines. NATO ASJ Vaccine design: The role of cytokine networks. Cape Sounion Baech Greece 1996.
24. Crabtree JE. Cytokines in the pathogenesis of Helicobacter pylori infection. Ir J Med Sci 1997; 166: Suppl. 3: 2.
25. 1. Gut 1996; 39: 172-175.